Affiliation:
1. Center for Population-Level Bioethics, Rutgers University, New Brunswick, New Jersey
Abstract
AbstractSome HIV remission studies include a treatment interruption that seriously risks infecting participants’ sex partners with HIV. What, ethically, is owed to these nonparticipants? Until greater certainty emerges on what protections should be afforded nonparticipants of research studies, what I call a “low-hanging fruit” approach may help researchers and review bodies determine how to address infection risks to nonparticipants in these studies.
Funder
National Institutes of Health
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Immunology and Allergy
Reference28 articles.
1. Medical research, risk, and bystanders;Kimmelman;IRB,2005
2. Third-party risks in research: should IRBs address them?;Hausman;IRB,2007
3. Protecting third parties in human subjects research;Resnik;IRB,2006
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献